EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Significance of Cardiac Troponin in Cancer Patients

Kristóf Birgés iD, Béla Merkely iD, Andrea Ágnes Molnár

Cells · 10.08.2026 · 15 (16) · 1435

DOI: 10.3390/cells15161435 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 10.08.2026. Verfasst von Kristóf Birgés und 2 weiteren Autor:innen. Beteiligte Einrichtung: Heart and Vascular Center, Semmelweis University, 1122 Budapest, Hungary. Hauptthemen laut MEDLINE: Neoplasms, Troponin, Myocardium. Die Arbeit nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent advances in oncological therapies have significantly improved cancer survival rates. However, these therapies have also led to an increased risk of cardiovascular alterations. Cardiac troponin, which is well-known for its role in diagnosing myocardial damage, is gaining recognition as a biomarker in the field of cardio-oncology. Despite its clinical value, differential diagnosis remains challenging, as troponin levels can increase in numerous scenarios, particularly in cardio-oncology. While the most recognized cause is the cardiotoxicity associated with cancer therapy, malignant tumors may also directly impact the myocardium. Furthermore, different cardiac troponins, such as troponins T and I, may have distinct biomarker roles, adding to diagnostic complexity. This review aims to summarize the pathological conditions that cause elevated serum cardiac troponin levels in patients with malignancies. We explore the underlying mechanisms at the molecular and cellular levels and discuss potential clinical applications. We also highlight existing gaps in the current evidence and outline future research directions in this rapidly evolving field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsTroponinMyocardiumHumansBiomarkers, TumorAnimals

Stichwörter der Autor:innen

cancercardio-oncologytroponin

Substanzen

TroponinBiomarkers, Tumor

Autor:innen und Institutionen

  • Heart and Vascular Center, Semmelweis University, 1122 Budapest, Hungary.

ORCID-Profile: Kristóf Birgés, Béla Merkely

Förderung

  • European Union

Zitieren

APA

Birgés, K., Merkely, B., & Molnár, A. Á. (2026). Significance of Cardiac Troponin in Cancer Patients. Cells, 15(16), 1435. https://doi.org/10.3390/cells15161435

Vancouver

Birgés K, Merkely B, Molnár AÁ. Significance of Cardiac Troponin in Cancer Patients. Cells. 2026;15(16):1435. doi:10.3390/cells15161435

BibTeX
@article{Birgs2026,
  author = {Birgés, Kristóf and Merkely, Béla and Molnár, Andrea Ágnes},
  title = {Significance of Cardiac Troponin in Cancer Patients},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {16},
  pages = {1435},
  doi = {10.3390/cells15161435}
}
Kostenlos starten →